PHFR Pharmaceutical Formulations, Inc | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks
PHFR Pharmaceutical Formulations, Inc

An SI Board Since June 1998

Posts	SubjectMarks	Bans	Symbol
11	0	0	PHFR

Emcee: Charlie	Type: Unmoderated

Introduction Market Data Compact

Looking for some input...

< brief intro >

Pharmaceutical Formulations makes more than 120 types of generic drugs: pain relievers, cold and allergy medications, and antacids. The majority of its products are packaged under customers' own brand names, with less than 1% sold under the company's Health+Cross trade name. The firm sells to more than 50 retailers, largely drugstores, supermarkets, and mass merchandisers. Its largest customers include Revco/CVS (17% of sales), Walgreens (14% of sales), and Costco Wholesale (12% of sales). A sales force of 13 employees and 25 independent brokers markets Pharmaceutical Formulation's products nationwide.

Address: Pharmaceutical Formulations, Inc.
460 Plainfield Ave.
Edison, NJ 08818-1904
Phone: 732-985-7100
Fax: 732-819-3330

CEO: Charles E. LaRosa
CFO: Frank Marchese

shares outstanding - 30,228,320

float - 9,100,00

press releases:

Monday June 22, 10:48 am

Pharmaceutical Formulations, Inc. Receives Final FDA
Approval to Manufacture and Market Over-the-Counter
Cimetidine (national brand equivalent Tagamet(R)
HB(TM)200)

Wednesday June 3, 9:52 am

Pharmaceutical Formulations, Inc. Announces Plans to Sell
Store Brand OTC Pharmaceuticals in The United Kingdom

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
11	Institutional Interest for PHFR. Just type in the symbol. thomsoninvest.net	Due Diligence	-	4/10/2000
10	Anyone here? Or am I alone again? DD	Due Diligence	-	3/13/2000
9	Good question(s), I guess that is why the price per share is low.. PHFR is on	Charlie	-	7/1/1998
8	charlie, has the fda given any indication as to when sucalfate will be approved	m rosen	-	7/1/1998
7	Wow, charlie you have been busy... PHFR looks kind of promising... That sure wo	arriba	-	6/25/1998
6	With recent new developments, I think we are going to see an in crease in reven	Charlie	-	6/25/1998
5	RESEARCH AND DEVELOPMENT; PRODUCTS IN DEVELOPMENT, as of last 10K The Company	Charlie	-	6/24/1998
4	Sales and Marketing as of last 10K - The Company has 13 employees in sales and	Charlie	-	6/24/1998
3	Customers - as of last 10K The Company's customers consist of over 50 ret	Charlie	-	6/24/1998
2	This is interesting - In September 1991, the Company entered into an option a	Charlie	-	6/24/1998
1	Hey Charlie, Ill do some DD and see what we have here.... Yehaaaaaaaaaaaaa, ar	arriba	-	6/24/1998

Go to reply# or date (mm/dd/yy):